Comparison of Contrast-Enhanced Ultrasound Versus Magnetic Resonance Imaging in the Detection and Characterization of Uterine Leiomyomas.
Autor: | Chhabra P; Department of Radiology, Christiana Care Health Services, Newark, Delaware, USA., Daugherty R; Department of Radiology and Medical Imaging, University of Virginia Health, Charlottesville, Virginia, USA., LeNoir AM; Department of Heart and Vascular Center, Christiana Care Health Services, Newark, Delaware, USA., Grilli C; Department of Heart and Vascular Center, Christiana Care Health Services, Newark, Delaware, USA., Makai G; Department of Obstetrics and Gynecology, Christiana Care Health Services, Newark, Delaware, USA., Patel N; TriHealth-Good Samaritan Hospital, Cincinnati, Ohio, USA., DeMauro C; Department of Radiology, Christiana Care Health Services, Newark, Delaware, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine [J Ultrasound Med] 2021 Jun; Vol. 40 (6), pp. 1147-1153. Date of Electronic Publication: 2020 Sep 15. |
DOI: | 10.1002/jum.15495 |
Abstrakt: | Objectives: Uterine fibroids are common findings in women with pelvic pain and abnormal uterine bleeding. The reference standard test in the pretreatment evaluation of fibroids is contrast-enhanced magnetic resonance (MR) imaging. This study compared the number, size, location, and enhancement of uterine fibroids identified by contrast-enhanced ultrasound (CEUS) and MR. The aim of this study was to demonstrate that CEUS performs similarly to MR and could be used as an alternative imaging modality. Methods: In this prospective observational study, 26 women underwent transabdominal CEUS and MR examinations. Blinded to the original clinical MR interpretations, 2 readers reviewed the MR and CEUS studies for each patient. The number, size, location, and enhancement of each fibroid per patient were reported by MR and CEUS. A Pearson correlation coefficient was calculated for the number of fibroids identified by each modality. Results: In total, 126 fibroids were imaged: 115 (91.3%) were observed on both examinations; 9 (7.1%) were observed by MR only; and 2 (1.6%) were observed by CEUS only. A high correlation was found between the modalities for the number of fibroids identified per patient (r = 0.97; P < .001). There was also no significant difference between the modalities for each patient in the fibroid number, size, location, or enhancement. Conclusions: These findings suggest that transabdominal CEUS may represent an alternative to MR in pretreatment evaluation of uterine fibroids and could serve as a test of choice in patients with a contraindication to MR. (© 2020 American Institute of Ultrasound in Medicine.) |
Databáze: | MEDLINE |
Externí odkaz: |